| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF03256403 |
| P698 | PubMed publication ID | 21766904 |
| P50 | author | Douglas Rex | Q5301922 |
| P2093 | author name string | James Creeden | |
| Frank Junker | |||
| Sabine Vogel-Ziebolz | |||
| P2860 | cites work | Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay | Q21090079 |
| American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected] | Q28236229 | ||
| Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer | Q28243334 | ||
| Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology | Q28274937 | ||
| Detection of colorectal cancer using MALDI-TOF serum protein profiling | Q33239333 | ||
| Establishment of serum protein pattern for screening colorectal cancer using SELDI-TOF-MS. | Q33272532 | ||
| From the genome to the proteome--biomarkers in colorectal cancer | Q33302788 | ||
| Profiling tumor-associated autoantibodies for the detection of colon cancer | Q33331295 | ||
| Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. | Q33382136 | ||
| Limitations in SELDI-TOF MS whole serum proteomic profiling with IMAC surface to specifically detect colorectal cancer | Q33494754 | ||
| Uptake of population-based flexible sigmoidoscopy screening for colorectal cancer: a nurse-led feasibility study | Q33633657 | ||
| American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group | Q33875909 | ||
| Incidental extracolonic findings at CT colonography | Q33910193 | ||
| CT colonography: the next colon screening examination? | Q33989618 | ||
| Identification, characterization and utilization of tumor cell selectin ligands in the design of colon cancer diagnostics | Q34018426 | ||
| Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence | Q34173853 | ||
| Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats | Q34530414 | ||
| Colonography by CT, MRI and PET/CT combined with conventional colonoscopy in colorectal cancer screening and staging | Q34587817 | ||
| Autoantibodies to Ca2+ binding protein Calnuc is a potential marker in colon cancer detection. | Q34612923 | ||
| Optimal markers for real-time quantitative reverse transcription PCR detection of circulating tumor cells from melanoma, breast, colon, esophageal, head and neck, and lung cancers. | Q34631538 | ||
| DNA methylation biomarkers for blood-based colorectal cancer screening | Q34727314 | ||
| Detection of epithelial cells by RT-PCR targeting CEA, CK20, and TEM-8 in colorectal carcinoma patients using OncoQuick density gradient centrifugation system | Q34994942 | ||
| Specific detection of cytokeratin 20-positive cells in blood of colorectal and breast cancer patients by a high sensitivity real-time reverse transcriptase-polymerase chain reaction method | Q35790106 | ||
| Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer | Q36332337 | ||
| Colonoscopic screening for colon cancer | Q36424008 | ||
| Detection of cytokeratins 19/20 and guanylyl cyclase C in peripheral blood of colorectal cancer patients | Q36619385 | ||
| Screening tests for colorectal cancer: a menu of options remains relevant | Q36623391 | ||
| Update on colorectal cancer imaging | Q36678268 | ||
| Targeting serum antibody for cancer diagnosis: a focus on colorectal cancer | Q36709561 | ||
| Virtual colonoscopy in colorectal cancer screening | Q36795227 | ||
| Colorectal cancer epigenetics: the role of environmental factors and the search for molecular biomarkers | Q36844969 | ||
| From colonic polyps to colon cancer: pathophysiology, clinical presentation, screening and colonoscopic therapy | Q37017043 | ||
| Reducing the incidence and mortality of colon cancer: mass screening and colonoscopic polypectomy. | Q37099633 | ||
| Early detection of colon cancer: new tests on the horizon | Q37141998 | ||
| Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: potential implications for the surgical oncologist | Q37232431 | ||
| Not your father's colonoscopy: a high-tech future for screening and surveillance of colorectal cancer | Q37233331 | ||
| Noninvasive molecular biomarkers for the detection of colorectal cancer | Q37311403 | ||
| Colorectal cancer screening tests: pros and cons, and for whom? | Q37345866 | ||
| Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot. | Q37362516 | ||
| Circulating tumor cells in colorectal cancer: detection methods and clinical significance | Q37385286 | ||
| Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening | Q37395173 | ||
| MAGE-B2 autoantibody: a new biomarker for pediatric systemic lupus erythematosus | Q37396620 | ||
| MicroRNAs are novel biomarkers of colorectal cancer | Q37519532 | ||
| Uptake of colorectal cancer screening: system, provider and individual factors and strategies to improve participation | Q37630575 | ||
| Systematic identification and validation of candidate genes for detection of circulating tumor cells in peripheral blood specimens of colorectal cancer patients. | Q39925790 | ||
| Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients | Q39930752 | ||
| Development and evaluation of a colorimetric membrane-array method for the detection of circulating tumor cells in the peripheral blood of Taiwanese patients with colorectal cancer. | Q40336452 | ||
| Serological identification of human tumor antigens | Q41642426 | ||
| N-acetyl-beta-D-hexosaminidase and its isoenzymes A and B in blood serum and urine, as a potential colon cancer markers. | Q43233064 | ||
| Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme | Q43453781 | ||
| French colorectal cancer screening pilot programme: results of the first round | Q43902638 | ||
| Clusterin in stool: a new biomarker for colon cancer screening? | Q44117904 | ||
| Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults | Q44309212 | ||
| Macrophage migration inhibitory factor may be used as an early diagnostic marker in colorectal carcinomas | Q44758236 | ||
| The application of C12 biochip in the diagnosis and monitoring of colorectal cancer: systematic evaluation and suggestion for improvement | Q46484611 | ||
| Comparative studies of tissue inhibitor of metalloproteinases-1 in plasma, serum and tumour tissue extracts from patients with primary colorectal cancer | Q46788251 | ||
| Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables | Q46796652 | ||
| Novel blood-based, five-gene biomarker set for the detection of colorectal cancer | Q46802106 | ||
| Biotechnology. Researcher, two universities sued over validity of prostate cancer test | Q49028009 | ||
| Free DNA and carcinoembryonic antigen serum levels: an important combination for diagnosis of colorectal cancer. | Q51927595 | ||
| Serum interleukin 6 (IL-6) and C-reactive protein (CRP) levels in colorectal adenoma and cancer patients. | Q53317011 | ||
| Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer. | Q53496191 | ||
| Occlusive colon carcinoma: virtual colonoscopy in the preoperative evaluation of the proximal colon. | Q53751507 | ||
| Natural fluorescence spectroscopy of human blood plasma in the diagnosis of colorectal cancer: feasibility study and preliminary results. | Q54425278 | ||
| The significance of serum transforming growth factor beta 1 in detecting of gastric and colon cancers. | Q54633915 | ||
| The use of a colon cancer associated nuclear antigen CCSA-2 for the blood based detection of colon cancer | Q56656502 | ||
| Initial analyses of colon cancer-specific antigen (CCSA)-3 and CCSA-4 as colorectal cancer-associated serum markers | Q56743542 | ||
| Serum levels of matrix metalloproteinase-2 and -9 and conventional tumor markers (CEA and CA 19-9) in patients with colorectal and gastric cancers | Q58205756 | ||
| Plasma Lysophosphatidylcholine Levels: Potential Biomarkers for Colorectal Cancer | Q59210346 | ||
| Pretreatment serum levels of hematopoietic cytokines in patients with colorectal adenomas and cancer | Q59843814 | ||
| The diagnostic value of G-CSF measurement in the sera of colorectal cancer and adenoma patients | Q59843819 | ||
| Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology | Q71692767 | ||
| Diagnosis and monitoring of colorectal cancer by L6 blood serum polymerase chain reaction is superior to carcinoembryonic antigen-enzyme-linked immunosorbent assay | Q73497291 | ||
| Circulating gastrin and ghrelin levels in patients with colorectal cancer: correlation with tumour stage, Helicobacter pylori infection and BMI | Q79676910 | ||
| The role of primary care in colorectal cancer screening: experience from Czech Republic | Q80481606 | ||
| A highly sensitive method for the detection of p16 methylation in the serum of colorectal cancer patients | Q80536726 | ||
| Colon Cancer Screening Guidelines 2005: the fecal occult blood test option has become a better FIT | Q81013969 | ||
| Screening for colorectal cancer in Italy: 2005 survey | Q81155696 | ||
| Correlation of CK-20-positive cells in peripheral venous blood with serum CEA levels in patients with colorectal carcinoma | Q81394101 | ||
| Virtual colonoscopy | Q81402166 | ||
| Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases | Q81572398 | ||
| Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel | Q82164882 | ||
| ASGE guideline: colorectal cancer screening and surveillance | Q82971218 | ||
| Mutant p53 protein in the serum of patients with colorectal cancer: Correlation with the level of carcinoembryonic antigen and serum epidermal growth factor receptor | Q83188963 | ||
| CEA in activated macrophages. New diagnostic possibilities for tumor markers in early colorectal cancer | Q84365091 | ||
| P433 | issue | 3 | |
| P921 | main subject | colorectal cancer | Q188874 |
| colorectal cancer screening | Q19391980 | ||
| colorectal carcinoma | Q25493920 | ||
| P304 | page(s) | 129-141 | |
| P577 | publication date | 2011-06-01 | |
| P1433 | published in | Molecular Diagnosis and Therapy | Q15758832 |
| P1476 | title | Serum tests for colorectal cancer screening | |
| P478 | volume | 15 |
| Q35487013 | Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients Identified by Using a Genome-Wide High-Resolution Array |
| Q35633134 | Cost-effectiveness of colorectal cancer screening in Germany: current endoscopic and fecal testing strategies versus plasma methylated Septin 9 DNA. |
| Q38068828 | Developing proteomics-based biomarkers for colorectal neoplasms for clinical practice: opportunities and challenges |
| Q36934087 | Evaluation of serum nucleoside diphosphate kinase A for the detection of colorectal cancer |
| Q38232753 | Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis |
| Q91762580 | Gel-Based Proteomics of Clinical Samples Identifies Potential Serological Biomarkers for Early Detection of Colorectal Cancer |
| Q38947015 | Integrative analysis of the colorectal cancer proteome: potential clinical impact |
| Q35977849 | Molecular events in primary and metastatic colorectal carcinoma: a review |
| Q37402807 | Multiplexed VeraCode bead-based serological immunoassay for colorectal cancer. |
| Q50670809 | Photonic crystal materials and their application in biomedicine. |
| Q50075976 | Proteomics for early detection of colorectal cancer: recent updates |
| Q33631419 | Relationship between tumor and peripheral blood NPRL2 mRNA levels in patients with colorectal adenoma and colorectal cancer |
| Q35067899 | Simple patterned nanofiber scaffolds and its enhanced performance in immunoassay |
Search more.